{
    "data": [
        {
            "id": "6903709becb8a70001458808",
            "title": "Mounjaro And Zepbound Power Eli Lilly&#39;s 54% Revenue Jump In Q3, Hikes 2025 Forecast",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\"><strong>Eli Lilly and Co.</strong> (NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/LLY\" target=\"_blank\">LLY</a>) on Thursday reported better-than-expected third-quarter earnings and boosted its annual forecast, sending the stock higher.</p><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong><em>LLY stock is gaining positive traction. <a href=\"https://www.benzinga.com/quote/LLY\" rel=\"noreferrer noopener\" target=\"_blank\">See the full story here</a></em></strong></li>\n</ul><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">The U.S. <a href=\"https://www.benzinga.com/topic/weight-loss\" rel=\"noreferrer noopener\" target=\"_blank\">weight loss drug giant</a> reported quarterly revenue of $17.60 billion, up 54% year over year, beating the <a href=\"https://www.benzinga.com/earnings\" rel=\"noreferrer noopener\" target=\"_blank\">consensus of $16.02 billion</a>, driven by a 62% increase in volume, partially offset by a 10% decrease due to lower realized prices.</p><!--/$--><!--$--><p class=\"block core-block\">Key Products revenue grew to $11.98 billion in Q3 2025, led by Mounjaro and Zepbound.</p><!--/$--><!--$--><p class=\"block core-block\">The company reported an adjusted earnings per share of $7.02, a sharp jump from $1.18 a year ago, beating the consensus of $5.70.</p><!--/$--><!--$--><p class=\"block core-block\"><strong><em>Also Read: <a href=\"https://www.benzinga.com/news/health-care/25/10/48507071/eli-lilly-advances-ai-and-access-supercomputer-with-nvidia-zepbound-via-walmart\" rel=\"noreferrer noopener\" target=\"_blank\">Eli Lilly Advances AI And Access: Supercomputer With NVIDIA, Zepbound Via Walmart</a></em></strong></p><!--/$--><!--$--><div class=\"sc-fzzUx jSgJNL\"></div><!--/$--><!--$--><h2 class=\"wp-block-heading\">Weightloss Drugs</h2><!--/$--><!--$--><p class=\"block core-block\">Mounjaro’s revenue increased 109% for the quarter to $6.52 billion. U.S. revenue was $3.55 billion, an increase of 49%, reflecting strong demand, partially offset by lower realized prices.</p><!--/$--><!--$--><p class=\"block core-block\">Revenue outside the U.S. increased to $2.97 billion compared with $728.0 million in Q3 2024, primarily <a href=\"https://www.benzinga.com/pressreleases/25/10/n48521986/lilly-reports-third-quarter-2025-financial-results-highlights-r-d-pipeline-momentum-and-raises-202\" rel=\"noreferrer noopener\" target=\"_blank\">driven by volume growth</a>.</p><!--/$--><!--$--><div class=\"nativo-placement-in-content-ap\"></div><!--/$--><!--$--><p class=\"block core-block\">U.S. Zepbound revenue increased 184% to $3.57 billion, primarily driven by increased demand, partially offset by lower realized prices.</p><!--/$--><!--$--><p class=\"block core-block\">Verzenio (a breast cancer drug) revenue increased 7% to $1.47 billion, driven by volume growth.</p><!--/$--><!--$--><p class=\"block core-block\">Gross profit increased 57% to $14.59 billion. Gross margin was 82.9%, an increase of 1.9 percentage points, driven by a favorable product mix, partially offset by lower realized prices.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><h2 class=\"wp-block-heading\"><strong>Outlook</strong></h2><!--/$--><!--$--><p class=\"block core-block\">Eli Lilly raised fiscal year 2025 sales guidance from $60 billion-$62 billion to $63 billion-$63.5 billion versus the consensus of $61.65 billion.</p><!--/$--><!--$--><p class=\"block core-block\">The obesity drug maker raised 2025 adjusted earnings guidance <a href=\"https://www.benzinga.com/markets/earnings/25/08/46960692/eli-lillys-closely-watched-obesity-pill-orforglipron-shows-around-12-weight-loss-but-trails-novo-nordisk\" rel=\"noreferrer noopener\" target=\"_blank\">from $21.75-$23.00</a> to $23-$23.70 versus the consensus of $22.18.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">On Wednesday, Eli Lilly announced a planned investment of more than $1.2 billion to expand and modernize its Lilly del Caribe manufacturing site in Carolina, Puerto Rico.</p><!--/$--><!--$--><p class=\"block core-block\">Construction on the expanded oral solid medicine product manufacturing facility is estimated to begin in 2026, with plans to start producing medicine <a href=\"https://www.benzinga.com/pressreleases/25/10/n48496871/lilly-announces-more-than-1-2-billion-investment-in-puerto-rico-facility-to-boost-oral-medicine-ma\" rel=\"noreferrer noopener\" target=\"_blank\">by the end of 2028</a>. </p><!--/$--><!--$--><p class=\"block core-block\">The new investment will integrate advanced technologies and expand production capacity to support the portfolio of oral solid medicines in cardiometabolic health, neuroscience, oncology, and immunology.</p><!--/$--><!--$--><p class=\"block core-block\">The enhanced facility will be among those that will manufacture orforglipron, Lilly’s first oral weight loss drug.</p><!--/$--><!--$--><p class=\"block core-block\">Lilly estimates the project will generate up to 1,000 construction jobs and 100 additional high-tech manufacturing positions.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>LLY Price Action:</strong> Eli Lilly shares were up 2.29% at $832.16 at the time of publication on Thursday, <a href=\"https://www.benzinga.com/pro/\" rel=\"noreferrer noopener\" target=\"_blank\">according to Benzinga Pro data</a>.</p><!--/$--><!--$--><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong><em><a href=\"https://www.benzinga.com/node/48526401\" rel=\"noreferrer noopener\" target=\"_blank\">Takeda Lowers 2025 Outlook After Weak Q2 And Pipeline Impairment Charges</a></em></strong></li>\n</ul><!--/$--><!--$--><p class=\"block core-block\"><em>Photo by M7kk via Shutterstock</em></p><!--/$--><!--$--><div><div><div class=\"bz-campaign bz-campaign-bottom-48529099\" data-nosnippet=\"true\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div><div class=\"flex sm:hidden flex-col\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div></div></div></div></div><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/10/30/Weight-Loss-Injection-Pen---Mounjaro-Inj.jpeg",
            "link": "https://www.benzinga.com/markets/earnings/25/10/48529099/mounjaro-and-zepbound-power-eli-lillys-54-revenue-jump-in-q3-hikes-2025-forecast",
            "pub_date": "2025-10-30 22:05:19",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "690373ececb8a70001458ba6",
            "title": "Cleveland-Cliffs (CLF) Stock Is Sliding Thursday: What&#39;s Going On?",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\">Shares of <strong>Cleveland-Cliffs Inc</strong> (NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/CLF\" target=\"_blank\">CLF</a>) are trading lower Thursday after the company announced the pricing of a public offering of 75 million common shares. Here’s what investors <a href=\"https://www.benzinga.com/pressreleases/25/10/b48522176/cleveland-cliffs-inc-prices-public-offering-of-75-000-000-common-shares\" target=\"_blank\">need to know</a>.</p><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li>CLF shares are retreating from recent levels. <a href=\"https://www.benzinga.com/quote/CLF\" rel=\"noreferrer noopener\" target=\"_blank\">See the trading setup here.</a></li>\n</ul><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\"><strong>What To Know:</strong> The steelmaker expects to raise gross proceeds of approximately $964 million, implying a price of about $12.85 per share. CLF plans to use the funds to repay borrowings under its credit facility. This action increases the number of shares outstanding, a dilutive move that is putting pressure on the stock price.</p><!--/$--><!--$--><p class=\"block core-block\">The offering follows a recent surge in investor interest after CLF revealed it is exploring opportunities in the rare earth minerals sector. On its third-quarter call, CEO <strong>Lourenco Goncalves</strong> <a href=\"https://www.benzinga.com/trading-ideas/movers/25/10/48317211/cleveland-cliffs-explores-rare-earths-stock-soars\" target=\"_blank\">highlighted</a> the company is assessing ore and tailings sites in Minnesota and Michigan for rare earth potential. </p><!--/$--><!--$--><p class=\"block core-block\">This long-term strategic initiative aims to create a domestic supply chain for critical materials, but Thursday’s focus remains on the near-term impact of the stock dilution.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Benzinga Edge Rankings:</strong> <a href=\"http://benzinga.grsm.io/register174\" target=\"_blank\">Benzinga Edge</a> Rankings highlight the stock’s strong Momentum score of 81.66, despite a low Growth score of 10.15.</p><!--/$--><!--$--><!--/$--><!--$--><p class=\"block core-block\"><strong>CLF Price Action:</strong> Cleveland-Cliffs shares were down 12.82% at $12.28 at the time of publication on Thursday, <a href=\"https://www.benzinga.com/pro/\" rel=\"noreferrer noopener\" target=\"_blank\">according to Benzinga Pro data</a>.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Read Also: <a href=\"https://www.benzinga.com/markets/commodities/25/10/48525772/trump-hints-at-potential-very-large-scale-alaska-oil-and-gas-deal-with-china\" target=\"_blank\">Trump Hints At Potential ‘Very Large Scale’ Alaska Oil And Gas Deal With China</a></strong></p><!--/$--><!--$--><div class=\"sc-fzzUx jSgJNL\"></div><!--/$--><!--$--><h2 class=\"wp-block-heading\">How To Buy CLF Stock</h2><!--/$--><!--$--><p class=\"block core-block\">By now you're likely curious about how to participate in the market for Cleveland-Cliffs – be it to purchase shares, or even attempt to bet against the company.</p><!--/$--><!--$--><p class=\"block core-block\">Buying shares is typically done through a brokerage account. You can find a list of <a href=\"https://www.benzinga.com/money/best-stock-trading-platforms\" target=\"_blank\">possible trading platforms here.</a> Many will allow you to buy “fractional shares,” which allows you to own portions of stock without buying an entire share.</p><!--/$--><!--$--><div class=\"nativo-placement-in-content-ap\"></div><!--/$--><!--$--><p class=\"block core-block\">If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to “go short” a share of stock by lending you the shares to sell. The process of shorting a <a href=\"https://www.benzinga.com/money/how-to-short-a-stock\" target=\"_blank\">stock can be found at this resource.</a>  Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading – either way it allows you to profit off of the share price decline.</p><!--/$--><!--$--><p class=\"block core-block\"><em>Image: Shutterstock</em></p><!--/$--><!--$--><div><div><div class=\"bz-campaign bz-campaign-bottom-48530048\" data-nosnippet=\"true\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div><div class=\"flex sm:hidden flex-col\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div></div></div></div></div><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/10/30/Konskie--Poland---February-24--2024-Clev.jpeg",
            "link": "https://www.benzinga.com/trading-ideas/movers/25/10/48530048/cleveland-cliffs-clf-stock-is-sliding-thursday-whats-going-on",
            "pub_date": "2025-10-30 22:19:27",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "690373fbecb8a70001458baf",
            "title": "Cardinal Health Posts Upbeat Q1 Results, Joins Guardant Health, Glaukos, C.H. Robinson And Other Big Stocks Moving Higher On Thursday",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\">U.S. stocks were mixed, with the Dow Jones index gaining around 200 points on Thursday.</p><!--/$--><!--$--><p class=\"block core-block\">Shares of <strong>Cardinal Health, Inc.</strong> (NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/CAH\" target=\"_blank\">CAH</a>) rose sharply during Thursday's session after the company reported better-than-expected first-quarter financial results and raised its FY25 adjusted EPS <a href=\"https://www.benzinga.com/quote/CAH/earnings\" target=\"_blank\">guidance above estimates</a>.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">Cardinal Health reported quarterly earnings of $2.55 per share which beat the analyst consensus estimate of $2.18 per share. The company reported quarterly sales of $64.009 billion which beat the analyst consensus estimate of $59.197 billion.</p><!--/$--><!--$--><p class=\"block core-block\">Cardinal Health shares jumped 17.5% to $193.26 on Thursday.</p><!--/$--><!--$--><p class=\"block core-block\">Here are some other big stocks recording gains in today’s session.</p><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong>Guardant Health, Inc</strong>. (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/GH\" target=\"_blank\">GH</a>) shares jumped 29.3% to $93.45 after the company reported better-than-expected third-quarter financial results and raised its FY25 sales guidance above estimates.</li>\n<li><strong>Emergent BioSolutions Inc</strong>. (NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/EBS\" target=\"_blank\">EBS</a>) gained 29% to $12.11 after the company reported better-than-expected quarterly financial results and raised its FY25 sales guidance.</li>\n<li><strong>Glaukos Corporation</strong> (NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/GKOS\" target=\"_blank\">GKOS</a>) surged 28.7% to $99.20 after the company reported better-than-expected quarterly financial results and raised its FY25 sales guidance above estimates.</li>\n<li><strong>C.H. Robinson Worldwide, Inc</strong>. (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/CHRW\" target=\"_blank\">CHRW</a>) shares rose 21.3% to $156.66 after the company reported better-than-expected third-quarter adjusted EPS results.</li>\n<li><strong>Viavi Solutions Inc.</strong> (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/VIAV\" target=\"_blank\">VIAV</a>) gained 21.1% to $16.93 after the company reported first-quarter results above estimates and issued second-quarter guidance above expectations.</li>\n<li><strong>Perimeter Solutions, Inc. </strong>(NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/PRM\" target=\"_blank\">PRM</a>) rose 21% to $25.96 following upbeat earnings.</li>\n<li><strong>FormFactor, Inc. </strong>(NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/FORM\" target=\"_blank\">FORM</a>) gained 21% to $57.71 after the company reported better-than-expected third-quarter financial results and issued fourth-quarter guidance above estimates.</li>\n<li><strong>Metsera, Inc.</strong> (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/MTSR\" target=\"_blank\">MTSR</a>) rose 20.9% to $63.15 after Novo Nordisk confirmed it submitted an unsolicited proposal to acquire the company.</li>\n<li><strong>Immunovant, Inc.</strong> (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/IMVT\" target=\"_blank\">IMVT</a>) gained 20% to $26.00.</li>\n<li><strong>Bausch Health Companies Inc</strong>. (NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/BHC\" target=\"_blank\">BHC</a>) rose 15% to $6.79 after the company reported better-than-expected third-quarter financial results and raised its FY25 sales guidance.</li>\n<li><strong>Insmed Incorporated</strong> (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/INSM\" target=\"_blank\">INSM</a>) gained 11.8% to $186.35 after the company raised its FY2025 global ARIKAYCE sales guidance.</li>\n<li><strong>XPO, Inc.</strong> (NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/XPO\" target=\"_blank\">XPO</a>) rose 11.3% to $138.82 following strong quarterly earnings.</li>\n<li><strong>WESCO International, Inc</strong>. (NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/WCC\" target=\"_blank\">WCC</a>) rose 10% to $251.41 after posting upbeat quarterly results.</li>\n<li><strong>Calix, Inc</strong>. (NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/CALX\" target=\"_blank\">CALX</a>) gained 9.3% to $68.00 after the company reported better-than-expected third-quarter financial results and issued current-quarter guidance above estimates.</li>\n<li><strong>CommScope Holding Company, Inc.</strong> (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/COMM\" target=\"_blank\">COMM</a>) shares rose 8.1% to $17.02 after the company reported quarterly results above estimates.</li>\n<li><strong>Huntington Ingalls Industries, Inc</strong>. (NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/HII\" target=\"_blank\">HII</a>) gained 7.3% to $320.12 after the company reported third-quarter results above estimates.</li>\n<li><strong>Extreme Networks, Inc.</strong> (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/EXTR\" target=\"_blank\">EXTR</a>) jumped 7.2% to $19.31 following upbeat quarterly earnings.</li>\n<li><strong>Fox Corporation</strong> (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/FOX\" target=\"_blank\">FOX</a>) gained 6.4% to $57.83 after the company reported better-than-expected quarterly financial results and announced a $1.5 billion accelerated share buyback transaction.</li>\n<li><strong>Alphabet Inc.</strong> (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/GOOG\" target=\"_blank\">GOOG</a>) rose 5.2% to $289.57 following upbeat quarterly results.</li>\n</ul><!--/$--><!--$--><p class=\"block core-block\"><strong>Read This Next: </strong></p><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong><a href=\"https://www.benzinga.com/analyst-stock-ratings/price-target/25/10/48519346/top-wall-street-forecasters-revamp-amazon-expectations-ahead-of-q3-earnings\" target=\"_blank\">Top Wall Street Forecasters Revamp Amazon Expectations Ahead Of Q3 Earnings</a></strong></li>\n</ul><!--/$--><!--$--><p class=\"block core-block\">Photo via Shutterstock</p><!--/$--><!--$--><div><div><div class=\"bz-campaign bz-campaign-bottom-48530058\" data-nosnippet=\"true\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div><div class=\"flex sm:hidden flex-col\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div></div></div></div></div><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/10/30/Cardinal-Health-Logo-Sign-On-The-Buildin.jpeg",
            "link": "https://www.benzinga.com/trading-ideas/movers/25/10/48530058/cardinal-health-posts-upbeat-q1-results-joins-guardant-health-glaukos-c-h-robinson-and-other-big-stocks-moving-higher-on-thursday",
            "pub_date": "2025-10-30 22:19:43",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "69033755ecb8a70001456619",
            "title": "Taiwan Semiconductor Secures Permits To Launch A14 Wafer Fab Construction",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\"><strong>Taiwan Semiconductor Manufacturing Co.</strong> (NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/TSM\" target=\"_blank\">TSM</a>) obtained three construction permits for its new A14 <a href=\"https://www.benzinga.com/topic/tsmc\" rel=\"noreferrer noopener\" target=\"_blank\">wafer fabrication plant</a> in Taichung.</p><!--/$--><!--$--><p class=\"block core-block\">The chipmaker is preparing to begin construction, according to the Central Taiwan Science Park Bureau.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">The permits cover the chip production facility, a central utility plant for power and water, and three office buildings, the Taipei Times <a href=\"https://www.taipeitimes.com/News/biz/archives/2025/10/30/2003846321\" rel=\"noreferrer noopener\" target=\"_blank\">reported</a> on Wednesday.</p><!--/$--><!--$--><p class=\"block core-block\"><strong><em>Also Read: <a href=\"https://www.benzinga.com/markets/tech/25/10/48455303/taiwan-semiconductor-expands-in-japan-with-new-14-billion-chip-factory\" rel=\"noreferrer noopener\" target=\"_blank\">Taiwan Semiconductor Expands In Japan With New $14 Billion Chip Factory</a></em></strong></p><!--/$--><!--$--><h2 class=\"wp-block-heading\">A14 Technology Milestones</h2><!--/$--><!--$--><p class=\"block core-block\">The A14 technology, or 1.4-nanometer process, will be 15% faster than the 2nm process at the same power.</p><!--/$--><!--$--><div class=\"sc-SfCGz ciVbir\"></div><!--/$--><!--$--><p class=\"block core-block\">With a 30% power reduction, the 1.4nm chip will have the same speed as the 2nm, which is scheduled to start commercial production later this year.</p><!--/$--><!--$--><p class=\"block core-block\">The chipmaker plans to start construction by year-end and begin mass production in the second half of 2028, investing roughly $49 billion.</p><!--/$--><!--$--><p class=\"block core-block\">The new facility has the potential to generate 485.7 billion New Taiwanese dollars ($15.85 billion) in annual production value and create about 4,500 jobs.</p><!--/$--><!--$--><div class=\"nativo-placement-in-content-ap\"></div><!--/$--><!--$--><h2 class=\"wp-block-heading\">TSM Stock Outperforms Nasdaq 100</h2><!--/$--><!--$--><p class=\"block core-block\">Taiwan Semiconductor's stock has surged more than 54% year-to-date, outperforming the <strong>Nasdaq 100's</strong> 24% gain.</p><!--/$--><!--$--><p class=\"block core-block\">The chipmaker's strong rally reflects its pivotal role as a key supplier for Big Tech leaders, including <strong>Nvidia Corp</strong>. (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/NVDA\" target=\"_blank\">NVDA</a>) and <strong>Apple Inc</strong>. (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/AAPL\" target=\"_blank\">AAPL</a>).</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><h2 class=\"wp-block-heading\">Industry Commentary on U.S.-Taiwan Collaboration</h2><!--/$--><!--$--><p class=\"block core-block\">In a recent update, a tech industry insider <a href=\"https://www.benzinga.com/markets/tech/25/10/48428258/taiwan-didnt-steal-us-chip-jobs-it-helped-create-them-says-tech-insider\" target=\"_blank\">dismissed claims</a> that Taiwan is taking over the U.S. chip industry, highlighting that partnerships with Apple, Nvidia, and <strong>Broadcom Inc.</strong> (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/AVGO\" target=\"_blank\">AVGO</a>) are fueling job creation and enhancing America's global competitiveness.</p><!--/$--><!--$--><p class=\"block core-block\">Speaking with the Taipei Times, tech reporter <strong>Owen Lin</strong> said Taiwan's semiconductor sector supports U.S. growth by supplying advanced, cost-effective chips to major American technology companies.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Price Action:</strong> TSM stock was trading lower by 0.25% to $304.34 premarket at last check Thursday.</p><!--/$--><!--$--><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong><em><a href=\"https://www.benzinga.com/node/48502613\" rel=\"noreferrer noopener\" target=\"_blank\">Etsy Stock Tumbles As CEO Exit And Weak Holiday Outlook Rattle Investors</a></em></strong></li>\n</ul><!--/$--><!--$--><p class=\"block core-block\"><em>Photo by Jack Hong via Shutterstock</em></p><!--/$--><!--$--><div><div><div class=\"bz-campaign bz-campaign-bottom-48520688\" data-nosnippet=\"true\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div><div class=\"flex sm:hidden flex-col\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div></div></div></div></div><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/10/30/Taiwan-Semiconductor-Manufacturing-Co-.jpeg",
            "link": "https://www.benzinga.com/markets/tech/25/10/48520688/taiwan-semiconductor-secures-permits-to-launch-a14-wafer-fab-construction",
            "pub_date": "2025-10-30 18:00:56",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "6903380aecb8a7000145669a",
            "title": "Tesla Cybercab To Make APAC Debut At China&#39;s Annual Import Expo In Shanghai — Optimus Could Also Be Showcased",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\"><strong>Tesla Inc.</strong> (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/TSLA\" target=\"_blank\">TSLA</a>) is planning to showcase the Cybercab at China's Annual Import Expo in Shanghai as the highly awaited autonomous vehicle inches closer to production, with <a href=\"https://www.benzinga.com/markets/tech/25/10/48518730/tesla-gears-up-for-cybercab-production-at-gigafactory-texas-posts-multiple-job-listings\" target=\"_blank\">new job listings announced</a> by the EV giant.</p><!--/$--><!--$--><p class=\"block core-block\"><em>Check out the current price of TSLA </em><a href=\"https://benzinga.com/quote/TSLA\" target=\"_blank\"><em>here</em></a><em>.</em></p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><h2 class=\"wp-block-heading\">Cybercab To Debut In Asia Pacific Next Month</h2><!--/$--><!--$--><p class=\"block core-block\">The company will showcase its Cybercab at the expo, which will run from November 5 to November 10. Tesla's Vice President <strong>Tao Lin </strong>announced the decision on the Chinese social media platform <strong>Weibo </strong>on Thursday. The company could also reportedly showcase its <a href=\"https://www.benzinga.com/markets/tech/25/10/48397403/dan-ives-says-tesla-robotaxi-is-biggest-competitive-threat-to-uber-predicts-optimus-robots-would-be-in-peoples-houses-in-2-to-3-years\" target=\"_blank\">Optimus humanoid robot</a> at the expo.</p><!--/$--><!--$--><!--/$--><!--$--><p class=\"block core-block\">The company hasn't confirmed whether the Cybercab would hit the Chinese roads in the future. Tesla currently sells the Model Y, Model 3, Model S, Model X, as well as the <a href=\"https://www.benzinga.com/markets/asia/25/09/47493268/tesla-model-y-l-averaging-over-10000-daily-orders-since-launch-received-120000-orders-to-date-report\" target=\"_blank\">six-seater Model Y L</a>.</p><!--/$--><!--$--><h2 class=\"wp-block-heading\">Cybercab With A Steering Wheel, Roadster Production</h2><!--/$--><!--$--><p class=\"block core-block\">The news comes as Tesla Board Chair <strong>Robyn Denholm</strong> shared that the company could add a <a href=\"https://www.benzinga.com/markets/tech/25/10/48484642/teslas-cybercab-may-get-steering-wheel-pedals-coming-around-to-reality-says-ross-gerber\" target=\"_blank\">steering wheel and pedals</a> to the Cybercab to comply with safety regulations, as well as hinted that the Cybercab could be Tesla's Model 2, an affordable vehicle in the Tesla lineup.</p><!--/$--><!--$--><p class=\"block core-block\">Tesla is also reportedly looking to hire people to help with the production of its highly anticipated Roadster, as <a href=\"https://www.benzinga.com/markets/tech/25/10/48453724/tesla-roadster-production-may-be-imminent-as-company-posts-new-job-listing\" target=\"_blank\">a new job listing</a> shared by the company details a position for a battery engineer to work with the Roadster's production.</p><!--/$--><!--$--><!--/$--><!--$--><p class=\"block core-block\">Tesla scores well on Momentum and Quality metrics, while offering satisfactory Growth, but poor Value. Tesla also has a favorable price trend in the Short, Medium and Long term. For more such insights, sign up for<a href=\"https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound\" target=\"_blank\"> Benzinga Edge Stock Rankings</a> today!</p><!--/$--><!--$--><p class=\"block core-block\"><em>Check out more of Benzinga’s Future Of Mobility coverage by</em><a href=\"https://www.benzinga.com/topic/mobility\" target=\"_blank\"><em> following this link.</em></a></p><!--/$--><!--$--><div><div><div class=\"bz-campaign bz-campaign-bottom-48520789\" data-nosnippet=\"true\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div><div class=\"flex sm:hidden flex-col\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div></div></div></div></div><!--/$--><!--$--><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><a href=\"https://www.benzinga.com/markets/tech/25/10/48519612/amid-nvidia-partnership-uber-ceo-dara-khosrowshahi-makes-bold-autonomous-driving-prediction-should-we-allow-humans-to-drive\" target=\"_blank\"><strong>Amid Nvidia Partnership, Uber CEO Dara Khosrowshahi Makes Bold Autonomous Driving Prediction: ‘Should We Allow Humans To Drive…’</strong></a></li>\n</ul><!--/$--><!--$--><p class=\"block core-block\"><em>Photo: Shutterstock</em></p><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/10/30/Tesla.jpeg",
            "link": "https://www.benzinga.com/markets/tech/25/10/48520789/tesla-cybercab-to-make-apac-debut-at-chinas-annual-import-expo-in-shanghai-optimus-could-also-be-showcased",
            "pub_date": "2025-10-30 18:03:58",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        }
    ]
}